A detailed history of Allworth Financial LP transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 173 shares of TMCI stock, worth $524. This represents 0.0% of its overall portfolio holdings.

Number of Shares
173
Previous 38 355.26%
Holding current value
$524
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 02, 2025

BUY
$5.34 - $7.7 $720 - $1,039
135 Added 355.26%
173 $1,000
Q2 2025

Aug 07, 2025

BUY
$5.44 - $8.32 $141 - $216
26 Added 216.67%
38 $0
Q1 2025

Apr 30, 2025

SELL
$7.3 - $10.54 $153 - $221
-21 Reduced 63.64%
12 $0
Q4 2024

Jan 30, 2025

SELL
$4.66 - $8.78 $736 - $1,387
-158 Reduced 82.72%
33 $0
Q3 2024

Oct 23, 2024

BUY
$5.01 - $8.45 $165 - $278
33 Added 20.89%
191 $1,000
Q2 2024

Jul 23, 2024

BUY
$4.17 - $12.62 $658 - $1,993
158 New
158 $1,000
Q4 2022

Jan 13, 2023

BUY
$20.54 - $24.67 $636 - $764
31 New
31 $0

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $168M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.